QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)
QQQ   293.36 (+4.56%)
AAPL   148.03 (+4.86%)
MSFT   255.14 (+6.16%)
META   118.10 (+7.89%)
GOOGL   100.99 (+6.09%)
AMZN   96.54 (+4.46%)
TSLA   194.70 (+7.67%)
NVDA   169.23 (+8.24%)
NIO   12.78 (+21.71%)
BABA   87.56 (+9.64%)
AMD   77.63 (+5.78%)
T   19.28 (+1.42%)
MU   57.65 (+4.59%)
CGC   3.62 (+5.85%)
F   13.90 (+1.09%)
GE   85.97 (+0.36%)
DIS   97.87 (+3.36%)
AMC   7.23 (-2.69%)
PYPL   78.41 (+0.99%)
PFE   50.13 (+1.29%)
NFLX   305.53 (+8.75%)

Hookipa Pharma - HOOK Stock Forecast, Price & News

$1.06
+0.02 (+1.92%)
(As of 11/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.02
$1.07
50-Day Range
$1.00
$1.50
52-Week Range
$0.99
$3.40
Volume
252,607 shs
Average Volume
2.31 million shs
Market Capitalization
$57.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.25

Hookipa Pharma MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
584.0% Upside
$7.25 Price Target
Short Interest
Healthy
1.61% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.87mentions of Hookipa Pharma in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.09) to ($1.03) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars

Medical Sector

431st out of 1,043 stocks

Pharmaceutical Preparations Industry

190th out of 510 stocks

HOOK stock logo

About Hookipa Pharma (NASDAQ:HOOK) Stock

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

Receive HOOK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter.

HOOK Stock News Headlines

Aquestive Therapeutics: FDA Stymies Libervant Launch
HOOKIPA Announces Executive Leadership Changes
See More Headlines
Receive HOOK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hookipa Pharma and its competitors with MarketBeat's FREE daily newsletter.

HOOK Company Calendar

Last Earnings
11/12/2021
Today
11/30/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/23/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HOOK
Employees
56
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.25
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+584.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$-75,660,000.00
Net Margins
-715.76%
Pretax Margin
-715.75%

Debt

Sales & Book Value

Annual Sales
$18.45 million
Book Value
$2.07 per share

Miscellaneous

Free Float
52,189,000
Market Cap
$57.99 million
Optionable
Not Optionable
Beta
0.73

Key Executives

  • Mr. Joern Aldag (Age 60)
    Pres, CEO & Director
  • Mr. Daniel Pinschewer (Age 44)
    Founder & Chief Scientific Officer
  • Dr. Reinhard Kandera (Age 50)
    CFO & Director
  • Mr. Anders Lilja Ph.D. (Age 46)
    Sr. VP of Technical Devel.
  • Mrs. Nina Waibel
    Communications & Investor Relations Mang.













HOOK Stock - Frequently Asked Questions

Should I buy or sell Hookipa Pharma stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hookipa Pharma in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HOOK shares.
View HOOK analyst ratings
or view top-rated stocks.

What is Hookipa Pharma's stock price forecast for 2023?

5 analysts have issued 12-month target prices for Hookipa Pharma's shares. Their HOOK share price forecasts range from $3.00 to $11.00. On average, they expect the company's share price to reach $7.25 in the next twelve months. This suggests a possible upside of 584.0% from the stock's current price.
View analysts price targets for HOOK
or view top-rated stocks among Wall Street analysts.

How have HOOK shares performed in 2022?

Hookipa Pharma's stock was trading at $2.33 at the beginning of the year. Since then, HOOK stock has decreased by 54.5% and is now trading at $1.06.
View the best growth stocks for 2022 here
.

When is Hookipa Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023.
View our HOOK earnings forecast
.

How were Hookipa Pharma's earnings last quarter?

Hookipa Pharma Inc (NASDAQ:HOOK) released its quarterly earnings data on Friday, November, 12th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.52) by $0.09. The business earned $3.87 million during the quarter, compared to analyst estimates of $5.24 million. Hookipa Pharma had a negative trailing twelve-month return on equity of 61.17% and a negative net margin of 715.76%. During the same quarter in the prior year, the business posted ($0.53) earnings per share.

What other stocks do shareholders of Hookipa Pharma own?
When did Hookipa Pharma IPO?

(HOOK) raised $100 million in an IPO on Thursday, April 18th 2019. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch, SVB Leerink and RBC Capital Markets served as the underwriters for the IPO and Kempen was co-manager.

What is Hookipa Pharma's stock symbol?

Hookipa Pharma trades on the NASDAQ under the ticker symbol "HOOK."

Who are Hookipa Pharma's major shareholders?

Hookipa Pharma's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.22%), Royal Bank of Canada (0.53%), Renaissance Technologies LLC (0.26%), Virtu Financial LLC (0.08%), Group One Trading L.P. (0.00%) and Two Sigma Investments LP (0.07%). Insiders that own company stock include Anders Lilja, Igor Matushansky, Klaus Orlinger and Sofinnova Capital Vi Fcpr.
View institutional ownership trends
.

How do I buy shares of Hookipa Pharma?

Shares of HOOK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hookipa Pharma's stock price today?

One share of HOOK stock can currently be purchased for approximately $1.06.

How much money does Hookipa Pharma make?

Hookipa Pharma (NASDAQ:HOOK) has a market capitalization of $57.99 million and generates $18.45 million in revenue each year. The company earns $-75,660,000.00 in net income (profit) each year or ($1.53) on an earnings per share basis.

How can I contact Hookipa Pharma?

Hookipa Pharma's mailing address is 350 FIFTH AVENUE 72ND FLOOR SUITE 7240, NEW YORK NY, 10118. The official website for the company is www.hookipapharma.com. The company can be reached via phone at 431-890-6360, via email at ir@hookipapharma.com, or via fax at 43-1890-636-0399.

This page (NASDAQ:HOOK) was last updated on 11/30/2022 by MarketBeat.com Staff